SFM Stock Sprouts Farmers Market, Inc.
US · NasdaqGSLast in our picks 2026-10-25 — not in the current list; analysis below is from that screen
Healthy-food demand, store expansion, and differentiated merchandising support above-sector growth.
Future value: $92.64 (+39.82%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Strong growth momentum and attractive specialty-grocery positioning.
- ▾Below 50-day MA (-7.81%)
- ▾Near 52-week low (9.6% of range)
- ▸~40% upside to price target
Is SFM a buy right now?
Trend: SFM is trading below the 50-day average (-7.81%), RSI 67 — neutral momentum, with a 3-month return of -13.77%.
Valuation & quality: Sprouts Farmers Market, Inc. trades on a trailing P/E of 12.6, forward P/E 11.1, PEG 1.43, price-to-book 4.21; fundamentals show net margin 5.6%, return on equity 35.2%, revenue growth 4.7% year on year.
Analyst consensus: 14 analysts have a mean 12-month price target of $91.57 (+38.9% vs the last close; range $70.00 – $114.00), consensus rating “buy”.
Our screen: BUY (score 3) — Healthy-food demand, store expansion, and differentiated merchandising support above-sector growth.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +4.40% | +6.10% | +0.90% | +2.40% | +3.10% | -5.90% | -19.10% | -0.10% |
Fundamentals
Analyst price target
Technical signals
About Sprouts Farmers Market, Inc.
Sprouts Farmers Market, Inc., together with its subsidiaries, engages in the retailing of fresh, natural, and organic food products in the United States. The company operates healthy grocery stores; and lifestyle-friendly ingredients, such as organic, plant-based, keto, paleo, non-GMO, and gluten-free.
Sector: Consumer Defensive · Industry: Grocery Stores · United States · 36,000 employees · Website
Related Consumer Staples picks
Browse: all US stocks · Consumer Staples picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.